Division of Plastic Surgery, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Av. Dr. Enéas de Carvalho Aguiar, 255, São Paulo, 05403-000, Brazil.
Sociedade Brasileira de Cirurgia Plástica (SBCP), São Paulo, Brazil.
Aesthetic Plast Surg. 2024 Jun;48(12):2321-2329. doi: 10.1007/s00266-023-03820-2. Epub 2024 Jan 18.
Post-burn hypertrophic scars are an important cause of physical discomfort, limitation of movements, psychological disorders, low self-esteem and reduced quality of life. Treatment for this condition is complex and involves several options. Microneedling, also known as minimally invasive percutaneous collagen induction, is an affordable minimally invasive option that can be combined with other treatments, including ablative ones.
The goal of this study was to present our microneedling approach for the treatment of hypertrophic scars after burns.
A prospective study of 15 patients with post-burn hypertrophic scars was conducted between October 2016 and June 2022. All patients were treated with microneedling and drug delivery of triamcinolone. Scars were evaluated using Vancouver Scar Scale (VSS), Burn Scar Assessment Scale (BSAS) and angle measurement for amplitude of movement evaluation of joints.
A significant improvement in the VSS score was obtained after microneedling (8.8 ± 0.44 to 4.1 ± 0.98; p = 0.012), especially in the acute group (less than 1 year after burns): 9.3 ± 0.49 to 3.5 ± 1.36; p = 0.041. There was a significant and progressive improvement of the scars throughout the treatment sessions in all criteria evaluated and in the ranges of joint movement (p = 0.012).
Our microneedling protocol promoted a significant improvement of post-burn scars, especially in acute hypertrophic scars, and in the amplitude of joint motion. Sequential treatments provided progressive improvement.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
烧伤后增生性瘢痕是导致躯体不适、运动受限、心理障碍、自卑和生活质量下降的重要原因。这种疾病的治疗方法复杂,涉及多种选择。微针治疗,也称为微创经皮胶原诱导,是一种负担得起的微创选择,可以与其他治疗方法(包括消融性治疗方法)结合使用。
本研究旨在介绍我们用于治疗烧伤后增生性瘢痕的微针治疗方法。
2016 年 10 月至 2022 年 6 月期间,对 15 例烧伤后增生性瘢痕患者进行了前瞻性研究。所有患者均接受微针治疗和曲安奈德药物输送。使用温哥华瘢痕量表(VSS)、烧伤瘢痕评估量表(BSAS)和关节活动幅度角测量评估瘢痕。
微针治疗后 VSS 评分显著改善(8.8 ± 0.44 至 4.1 ± 0.98;p = 0.012),特别是在急性组(烧伤后 1 年内):9.3 ± 0.49 至 3.5 ± 1.36;p = 0.041。在所有评估标准和关节运动范围中,整个治疗过程中瘢痕均有显著且逐渐的改善(p = 0.012)。
我们的微针治疗方案显著改善了烧伤后瘢痕,特别是急性增生性瘢痕和关节运动幅度。序贯治疗可逐步改善。
证据等级 IV:本刊要求作者为每篇文章指定证据等级。有关这些循证医学评级的完整描述,请参阅目录或在线作者指南 www.springer.com/00266 。